These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28633317)

  • 1. Discussion: The FDA is Unprepared for Personalized Medicine.
    Tabarrok A
    Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends.
    Liu Q; Ahadpour M; Rocca M; Huang SM
    AAPS J; 2021 Apr; 23(3):54. PubMed ID: 33846878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexibility in the FDA approach to orphan drug development.
    Hunter NL; Rao GR; Sherman RE
    Nat Rev Drug Discov; 2017 Nov; 16(11):737-738. PubMed ID: 28860647
    [No Abstract]   [Full Text] [Related]  

  • 4. Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.
    Issa AM; Thorogood A; Joly Y; Knoppers BM
    Genet Med; 2019 Mar; 21(3):542-544. PubMed ID: 29988078
    [No Abstract]   [Full Text] [Related]  

  • 5. From Molecule to Patient and Ways to Get the Dose Precisely Right.
    Vinks AA
    Clin Pharmacol Ther; 2019 Mar; 105(3):534-537. PubMed ID: 30773626
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health.
    Zuckerman DM
    Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730
    [No Abstract]   [Full Text] [Related]  

  • 7. Discussion: The role, position, and function of the FDA-The past, present, and future.
    Fleming TR; Demets DL; McShane LM
    Biostatistics; 2017 Jul; 18(3):417-421. PubMed ID: 28633307
    [No Abstract]   [Full Text] [Related]  

  • 8. Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Alcohol Clin Exp Res; 2020 Jan; 44(1):23-35. PubMed ID: 31803968
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of genetic tests in the era of personalized medicine].
    Molnár JM; Magyarósi S; Németh G
    Magy Onkol; 2013 Mar; 57(1):16-20. PubMed ID: 23573517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Regulatory Aspects of Companion Diagnostic Development in Oncology.
    Jørgensen JT; Hersom M
    Clin Pharmacol Ther; 2018 Jun; 103(6):999-1008. PubMed ID: 29197081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can precision medicine reduce overdiagnosis?
    Hunt S; Jha S
    Acad Radiol; 2015 Aug; 22(8):1040-1. PubMed ID: 26100198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An appraisal of drug development timelines in the Era of precision oncology.
    Jardim DL; Schwaederle M; Hong DS; Kurzrock R
    Oncotarget; 2016 Aug; 7(33):53037-53046. PubMed ID: 27419632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulations, economics hindering adoption of personalized medicine.
    Thompson CA
    Am J Health Syst Pharm; 2011 Mar; 68(5):372-4. PubMed ID: 21330674
    [No Abstract]   [Full Text] [Related]  

  • 14. Dearth of clinically useful diagnostics limits growth of personalized medicine.
    Cohen J
    Expert Rev Clin Pharmacol; 2011 Sep; 4(5):527-9. PubMed ID: 22220302
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration.
    Lyons E; Donohue K; Lee JJ
    Gastroenterology; 2019 Aug; 157(2):275-277. PubMed ID: 31022402
    [No Abstract]   [Full Text] [Related]  

  • 16. Data Integrity: History, Issues, and Remediation of Issues.
    Rattan AK
    PDA J Pharm Sci Technol; 2018; 72(2):105-116. PubMed ID: 29158286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FDA Oncology Center of Excellence and precision medicine.
    Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
    Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine.
    Evans JP; Watson MS
    JAMA; 2015 Feb; 313(7):669-70. PubMed ID: 25560537
    [No Abstract]   [Full Text] [Related]  

  • 19. Messing with home brews.
    Nat Biotechnol; 2007 Mar; 25(3):262. PubMed ID: 17344864
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward a Personalized Use of Paclitaxel.
    Russo GL
    Recent Pat Anticancer Drug Discov; 2019; 14(4):296-297. PubMed ID: 31920185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.